論文

査読有り 国際誌
2020年1月27日

Ghrelin-insulin-like growth factor-1 axis is activated via autonomic neural circuits in the non-alcoholic fatty liver disease.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • Takuro Nagoya
  • Kenya Kamimura
  • Ryosuke Inoue
  • Masayoshi Ko
  • Takashi Owaki
  • Yusuke Niwa
  • Norihiro Sakai
  • Toru Setsu
  • Akira Sakamaki
  • Takeshi Yokoo
  • Hiroteru Kamimura
  • Yuka Nakamura
  • Masaki Ueno
  • Shuji Terai
  • 全て表示

開始ページ
e13799
終了ページ
記述言語
英語
掲載種別
DOI
10.1111/nmo.13799

BACKGROUND: The correlation of the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) with non-alcoholic fatty liver disease (NAFLD) has been reported in epidemiological studies. However, the mechanisms of molecular and inter-organ systems that render these factors to influence on NAFLD have not been elucidated. In this study, we examined the induction of ghrelin which is the GH-releasing hormone and IGF-1, and involvement of autonomic neural circuits, in the pathogenesis of NAFLD. METHODS: The expression of gastric and hypothalamic ghrelin, neural activation in the brain, and serum IGF-1 were examined in NAFLD models of choline-deficient defined l-amino-acid diet-fed, melanocortin 4 receptor knockout mice, and partial hepatectomy mice with or without the blockades of autonomic nerves to test the contribution of neural circuits connecting the brain, liver, and stomach. KEY RESULTS: The fatty changes in the liver increased the expression of gastric ghrelin through the autonomic pathways which sends the neural signals to the arcuate nucleus in the hypothalamus through the afferent vagal nerve which reached the pituitary gland to release GH and then stimulate the IGF-1 release from the liver. In addition, high levels of ghrelin expression in the arcuate nucleus were correlated with NAFLD progression regardless of the circuits. CONCLUSIONS: Our study demonstrated that the fatty liver stimulates the autonomic nervous signal circuits which suppress the progression of the disease by activating the gastric ghrelin expression, the neural signal transduction in the brain, and the release of IGF-1 from the liver.

リンク情報
DOI
https://doi.org/10.1111/nmo.13799
ID情報
  • DOI : 10.1111/nmo.13799

エクスポート
BibTeX RIS